A detailed history of New Millennium Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, New Millennium Group LLC holds 7 shares of EW stock, worth $474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$474
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$84.3 - $94.31 $590 - $660
7 New
7 $0
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $15,033 - $20,263
-217 Reduced 55.78%
172 $11,000
Q2 2023

Aug 03, 2023

SELL
$81.41 - $94.33 $13,676 - $15,847
-168 Reduced 30.16%
389 $36,000
Q1 2023

Apr 28, 2023

SELL
$74.26 - $84.51 $74 - $84
-1 Reduced 0.18%
557 $46,000
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $341 - $437
-5 Reduced 0.89%
558 $41,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $164 - $214
-2 Reduced 0.35%
563 $47,000
Q2 2022

Aug 18, 2022

BUY
$86.5 - $128.27 $48,872 - $72,472
565 New
565 $54,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.